文献速递癫痫帕金森病与运动障碍

ADCY5相关运动障碍:从长期误诊为耐药性癫痫说起

Pearls & Oy-sters: ADCY5-Related Dyskinesia: From a Longstanding Misdiagnosis of Drug-Resistant Epilepsy.
PubMed 文献 · Neurology · 2025-04-29

本文报告一例59岁女性,自2岁起出现睡眠相关阵发性不自主运动,被误诊为耐药性癫痫57年,经视频脑电图记录到睡眠N1/N2期非癫痫性事件及ADCY5基因检测确诊为ADCY5相关运动障碍。咖啡因及逐步撤停抗癫痫发作药物(保留氯硝西泮)后,发作频率和强度均减少。作者建议对成人阵发性睡眠相关事件考虑ADCY5-RD等替代诊断。

要点

  • ADCY5-RD以儿童期起病的运动增多为特征,阵发性加重及睡眠/觉醒相关运动是标志性表现。
  • 长期误诊为耐药性癫痫的成人睡眠相关阵发性事件,应通过视频脑电图及基因检测重新评估。
  • 咖啡因和逐步撤停抗癫痫发作药物(保留氯硝西泮)后,本例阵发性发作频率和强度均减少。

核心结论

  • ADCY5-RD可自儿童期起病并被长期误诊为耐药性癫痫,视频脑电图和ADCY5基因检测有助于确诊。
  • 对成人阵发性睡眠相关事件应考虑ADCY5-RD等替代诊断。

研究设计与样本

  • 本文为单病例报告(Pearls & Oy-sters),报告一例59岁女性ADCY5-RD患者的诊疗经过。

主要发现

  • 患者自2岁起出现睡眠相关阵发性非自主运动,并伴有持续性进行性构音障碍和轴性肌张力减低,以及发作性口面部肌张力障碍。
  • 长时间视频脑电图监测记录到睡眠起始的非癫痫性事件,始于NREM睡眠N1和N2期。
  • ADCY5基因检测确诊ADCY5-RD;咖啡因及逐步撤停抗癫痫发作药物(保留氯硝西泮)后,阵发性发作强度减轻、频率减少。

关键数值与推荐

  • ADCY5-RD于2012年首次描述,可能存在更多在儿童期被误诊的成人患者。
  • 目前尚无ADCY5-RD的治疗指南,腺苷A2A受体拮抗剂已成为有前景的治疗选择。

临床怎么用

  • 对成人阵发性睡眠相关事件,应考虑ADCY5-RD等替代诊断,并通过视频脑电图和基因检测进行评估。
  • 本例中咖啡因及逐步撤停抗癫痫发作药物(保留氯硝西泮)后,阵发性发作频率和强度均减少。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

ADCY5-related dyskinesia (ADCY5-RD) is a hyperkinetic movement disorder of childhood onset, resulting from pathogenic variants in the ADCY5 gene. Paroxysmal worsening of the movements and movements that occur in relation to sleep and/or awakenings are hallmarks of ADCY5-RD. ADCY5-RD is therefore often misdiagnosed as sleep-related hypermotor epilepsy, sleep disorders, paroxysmal hyperkinesias, childhood onset chorea, or psychogenic events. In this case, a 59 year-old woman with a longstanding misdiagnosis of drug-resistant epilepsy was ultimately diagnosed with ADCY5-RD following video EEG. She had been followed for paroxysmal episodes of nonvoluntary movements mostly occurring during sleep since 2 years of age. She also exhibited continuous progressive dysarthria and axial hypotonia. Episodic orofacial dystonia was present as well. For 57 years, these symptoms had been treated with various combinations of antiseizure medications. However, the diagnosis was reconsidered when prolonged video-EEG monitoring recorded sleep-onset nonepileptic events, starting during N1 and N2 stages of NREM sleep. Genetic testing of ADCY5 confirmed the diagnosis. Caffeine and progressive withdrawal of antiseizure medications except clonazepam resulted in clinical improvement in paroxysms, which became less intense and less frequent. Given that ADCY5-RD was first described in 2012, there may be more adult patients misdiagnosed in childhood. Thus, we recommend considering alternative diagnosis for adult patients with paroxysmal sleep-related events to detect ADCY5-RD in adults. Although there are still no treatment guidelines for ADCY5-RD, adenosine-2A receptor antagonists have emerged as a promising therapeutic option.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Moreno-Estébanez A, Sánchez-Horvath M, Marinas A, et al. Pearls & Oy-sters: ADCY5-Related Dyskinesia: From a Longstanding Misdiagnosis of Drug-Resistant Epilepsy. Neurology. 2025. PMID: 40300124. doi:10.1212/WNL.0000000000213661

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。